Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
31 March 2017
E-002438-17
Question for written answer
to the Commission
Rule 130
Maria Spyraki (PPE)

 Subject:  Shortages of medicines and Greek National Health Service Organisation debts
 Answer(s) 

Greek pharmacies are facing a severe problem as, on top of the current shortage of medicines, they are also having to manage delays in the settling of overdue debts owed by the Greek National Health Service Organisation (EOPPY). As a matter of fact, the overdue debts date back to 2013. Given that directive 2011/62/EU requires all EU Member States, to have adequate supplies of medicines, can the Commission say:

1. As they are endangering the viability of the sector and the adequacy of medicines in the Greek market, how will overdue debts to these pharmacies be addressed?
2. For the Pharmaceutical Association of Thessaloniki alone, the overdue debt is for insurance fund prescriptions and stands at EUR 2 348 655.38. How can the debt be dealt with?
3. How will pharmacy liquidity be ensured as the delay in consolidating the health sector of the insurance funds drags on and on?

Original language of question: EL 
Last updated: 8 May 2017Legal notice